EPHA2 and glioblastoma: In conclusion, we have identified EphA2 as an important host factor mediating entry and fusion of HCMV with glioblastoma cells, which may assist future studies striving for a better understanding of how HCMV infects glioblastoma cells and for potential new targets of innovative antiviral strategies.